Which of the following is not an adverse effect of cimetidine?
Which of the following is not considered a prokinetic agent?
What is the primary use of Pirenzepine?
Which of the following medications is classified as a stool softener?
Which of the following drugs is not used for the treatment of H. Pylori?
What is the drug of choice for drug-induced peptic ulcer?
Why do NSAIDs cause gastric ulcers?
Drug that binds bile acids in the intestine and prevents their return to liver via the enterohepatic circulation?
Which of the following is classified as an antispasmodic agent?
Which of the following is the most common side effect of Cimetidine?
Explanation: ***Decreased prolactin levels*** - Cimetidine, an **H2 receptor antagonist**, is known to **increase prolactin levels** due to its anti-androgenic effects and effects on dopamine regulation, not decrease them. - This elevation in prolactin can lead to side effects such as **galactorrhea** and **gynecomastia**. *Confusional state, restlessness* - Cimetidine can cross the **blood-brain barrier** and block H2 receptors in the central nervous system, leading to **CNS side effects** like confusion, disorientation, agitation, and hallucinations, especially in elderly patients or those with renal impairment. - These effects are less common with newer H2 blockers that have lower CNS penetration. *Gynecomastia* - Cimetidine has **anti-androgenic effects** by binding to androgen receptors and inhibiting the metabolism of estrogens, which can lead to an increase in estrogen-to-androgen ratio. - This imbalance can result in increased breast tissue development in males, known as **gynecomastia**, and also **sexual dysfunction**. *Dry mouth* - Dry mouth is **not a recognized adverse effect** of cimetidine, as H2 receptor antagonists do not possess anticholinergic properties [1]. - Unlike anticholinergic drugs that block muscarinic receptors [1], cimetidine specifically blocks histamine H2 receptors and does not interfere with salivary secretion. - This option may serve as a distractor, as dry mouth is commonly associated with other drug classes but not with H2 blockers [1].
Explanation: Diphenylmethane derivatives (e.g., bisacodyl, sodium picosulfate) are stimulant laxatives, not prokinetic agents. While they do increase colonic motility, they work by direct stimulation of the colonic mucosa and myenteric plexus, causing increased water secretion and peristalsis [3]. Prokinetic agents specifically enhance coordinated gastrointestinal motility through modulation of neurotransmitters (acetylcholine, dopamine, serotonin, motilin), whereas laxatives work through different mechanisms (osmotic effects, stimulation, bulk formation). Therefore, diphenylmethane derivatives are classified as laxatives, not prokinetics. Dopamine antagonist - Dopamine antagonists like metoclopramide and domperidone block D2 receptors in the chemoreceptor trigger zone and GI tract, enhancing acetylcholine release and promoting gastric emptying [2]. - They are commonly used as prokinetic agents and antiemetics [2]. 5HT4 agonist - 5HT4 agonists (e.g., cisapride, prucalopride) stimulate serotonin receptors in the enteric nervous system, increasing acetylcholine release and enhancing colonic motility [1]. - They are effective prokinetic agents for conditions like chronic constipation and gastroparesis [1]. Macrolides - Certain macrolide antibiotics, such as erythromycin, act as motilin receptor agonists at sub-antibiotic doses. - By mimicking motilin, they stimulate gastric and intestinal contractions (phase III of migrating motor complex), functioning as prokinetic agents.
Explanation: ***Gastric ulcer*** - **Pirenzepine** is a selective **M1 muscarinic antagonist** used to block acetylcholine's effects on gastric parietal cells. - By inhibiting M1 receptors, it **reduces gastric acid secretion**, thus facilitating the healing of gastric ulcers. *Glaucoma* - **Glaucoma** treatment primarily involves reducing intraocular pressure, often with **beta-blockers** or **prostaglandin analogs**. - Pirenzepine's mechanism of action is irrelevant to the **pathophysiology of glaucoma**. *Hypertension* - **Hypertension** is managed by various classes of drugs that target blood pressure regulation, such as **ACE inhibitors** or **calcium channel blockers**. - Pirenzepine does not have a direct role in the **management of blood pressure**. *Congestive cardiac failure* - **Congestive cardiac failure** treatment focuses on improving cardiac output and reducing fluid overload with drugs like **diuretics** or **ACE inhibitors**. - Pirenzepine has no therapeutic application in the **treatment of heart failure**.
Explanation: **Docusates** - **Docusates** (e.g., docusate sodium, docusate calcium) are **stool softeners** that work by reducing the surface tension of stool, allowing water and lipids to penetrate. - This increases the water content in the stool, making it softer and easier to pass, which is particularly useful in preventing straining after surgery or in conditions like hemorrhoids. *Bran* - **Bran** is a **bulk-forming laxative**, a type of dietary fiber that adds mass to the stool. - It absorbs water in the intestines, which increases stool volume and stimulates bowel movements, but it does not directly soften the stool in the same way docusates do. *Senna* - **Senna** is a **stimulant laxative** that works by irritating the bowel wall to promote peristalsis and bowel evacuation. - While it can help move stool, it does not act primarily by softening it, and prolonged use can lead to dependency or electrolyte imbalances. *Phenolphthalein* - **Phenolphthalein** is a **stimulant laxative** that was historically used to promote bowel movements. - It is no longer widely used due to concerns about potential carcinogenicity and other adverse effects, and it does not function as a stool softener.
Explanation: ***Correct: Domperidone*** - Domperidone is a **prokinetic drug** used to treat nausea, vomiting, and gastric motility disorders, but it has **no direct antibacterial activity** against *H. pylori*. - It works by blocking **dopamine receptors** in the chemoreceptor trigger zone and peripherally. - Therefore, it is **NOT used for *H. pylori* eradication**. *Incorrect: Bismuth* - **Bismuth subsalicylate** is a key component of **quadruple therapy** for *H. pylori* eradication, particularly in cases of antibiotic resistance or treatment failure. - It has **bactericidal effects** against *H. pylori*, disrupts its cell wall, and inhibits its adherence to the gastric mucosa. *Incorrect: Amoxicillin* - **Amoxicillin** is a penicillin-class antibiotic commonly used in various *H. pylori* eradication regimens, including **triple therapy**. - It acts by **inhibiting bacterial cell wall synthesis**, leading to bacterial lysis. *Incorrect: Clarithromycin* - **Clarithromycin** is a macrolide antibiotic frequently included in standard **triple therapy** for *H. pylori* eradication. - It inhibits **bacterial protein synthesis** by binding to the 50S ribosomal subunit.
Explanation: ***Proton pump inhibitors*** - **PPIs** are the most effective agents for treating and preventing **NSAID-induced peptic ulcers** by profoundly suppressing gastric acid secretion. - They provide **rapid symptom relief** and promote ulcer healing by creating an environment conducive to mucosal repair. *Prostaglandin analogues* - **Misoprostol**, a prostaglandin E1 analogue, can prevent NSAID-induced ulcers, but its use is limited by **gastrointestinal side effects** such as diarrhea and abdominal cramping. - While they protect the gastric mucosa, their efficacy in healing established ulcers is generally **inferior to PPIs**. *H2-receptor antagonists* - **H2-blockers** are effective in reducing gastric acid, but they are **less potent** than PPIs and typically do not heal **gastric ulcers** as effectively, especially those induced by NSAIDs. - They are more commonly used for preventing **duodenal ulcers** and managing symptoms of GERD. *Antacids* - Antacids provide **immediate, temporary relief** of ulcer symptoms by neutralizing existing stomach acid. - They do not address the underlying pathology or promote **ulcer healing** and are therefore not considered the drug of choice for treatment.
Explanation: ***They inhibit COX-1 and COX-2 enzymes*** - NSAIDs primarily exert their anti-inflammatory effects by inhibiting **cyclooxygenase (COX) enzymes**, specifically COX-1 and COX-2. - While COX-2 inhibition is responsible for anti-inflammatory action, **COX-1 inhibition** reduces the production of protective prostaglandins in the gastric mucosa, leading to a loss of mucosal integrity and an increased risk of ulceration. *They inhibit the production of protective mucus* - While NSAIDs do compromise the gastric mucosal barrier, their primary mechanism is not a direct inhibition of mucus production itself. - Instead, the reduced prostaglandin synthesis indirectly affects the quantity and quality of mucus and bicarbonate, which are crucial for mucosal defense. *They increase gastric acid secretion* - NSAIDs do not directly increase gastric acid secretion; in fact, some studies suggest a mild inhibitory effect. - The main problem is the diminished mucosal protection against the normal levels of gastric acid. *They delay gastric emptying* - Delaying gastric emptying is not a primary mechanism by which NSAIDs cause ulcers. - While some medications can affect gastric motility, this is not the key pathway for NSAID-induced gastropathy.
Explanation: ***Cholestyramine*** - **Cholestyramine** is a **bile acid-binding resin** that sequesters bile acids in the intestine, preventing their reabsorption. - This interruption of the **enterohepatic circulation** leads to increased synthesis of new bile acids from cholesterol in the liver, thus lowering plasma LDL cholesterol. *Niacin* - **Niacin (nicotinic acid)** reduces the hepatic synthesis and secretion of **VLDL**, which in turn lowers LDL and triglyceride levels. - It works primarily through mechanisms related to fat metabolism in the liver and adipose tissue, not direct bile acid binding in the intestine. *Fenofibrate* - **Fenofibrate** is a **PPAR-α agonist** that primarily reduces triglyceride levels by increasing fatty acid oxidation and lipoprotein lipase activity, and secondarily increases HDL. - Its main action is on lipid metabolism in the liver and peripheral tissues, not by binding bile acids in the gut. *Gugulipid* - **Gugulipid** is a phytosterol derived from the guggul tree, sometimes used in traditional medicine for cholesterol management. - Its purported mechanism involves increasing **bile acid excretion** and inhibiting cholesterol biosynthesis, but it does not directly bind bile acids in the same manner as resins like cholestyramine.
Explanation: ***Dicyclomine*** - **Dicyclomine** is an **anticholinergic** medication that works by blocking muscarinic receptors, thereby reducing smooth muscle spasm in the gastrointestinal tract. - It is commonly used to treat symptoms of **irritable bowel syndrome (IBS)**, such as abdominal pain and cramping. *Physostigmine* - **Physostigmine** is a **cholinesterase inhibitor** that increases the concentration of acetylcholine at the synaptic cleft. - It is used to treat **anticholinergic poisoning** by reversing the effects of anticholinergic drugs, rather than acting as an antispasmodic itself. *Tropicamide* - **Tropicamide** is an **anticholinergic** agent primarily used as a **mydriatic** (pupil dilator) and **cycloplegic** (paralyzes the ciliary muscle) for ophthalmic examinations. - Its action is localized to the eye and it does not have significant systemic antispasmodic effects. *None of the options* - This option is incorrect because one of the listed medications is indeed classified as an antispasmodic agent. - When "None of the options" appears as a choice, it should only be selected if all other options are clearly incorrect.
Explanation: ***CNS effects (confusion, dizziness)*** - **Cimetidine** is a **H2-receptor antagonist** that can cross the **blood-brain barrier**, leading to **central nervous system (CNS) side effects**. - These effects, including **confusion, dizziness**, and **headache**, are more common in elderly patients or those with renal impairment due to reduced drug clearance. *Impotence* - While **cimetidine** can cause **endocrine effects** due to its anti-androgenic activity, **impotence** is a less common side effect compared to CNS disturbances. - It results from the drug's interference with **testosterone metabolism** and binding to **androgen receptors**. *Gynaecomastia* - **Gynaecomastia** is a known **endocrine side effect** of **cimetidine** due to its **anti-androgenic activity** and promotion of **prolactin release**. - However, CNS side effects are generally encountered more frequently in clinical practice. *Diarrhea* - **Gastrointestinal side effects** like **diarrhea** are possible with various medications, but they are not the most common or characteristic side effect of **cimetidine**. - Nausea and constipation are also reported, but generally less frequently than CNS effects.
Acid-Peptic Disease Therapeutics
Practice Questions
Proton Pump Inhibitors
Practice Questions
H2 Receptor Antagonists
Practice Questions
Antacids and Mucosal Protectants
Practice Questions
Antiemetics
Practice Questions
Prokinetic Agents
Practice Questions
Laxatives and Purging Agents
Practice Questions
Antidiarrheal Drugs
Practice Questions
Drugs for Inflammatory Bowel Disease
Practice Questions
Pancreatic Enzyme Supplements
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free